Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| type I pneumocyte | 12 studies | 62% ± 15% | |
| type II pneumocyte | 11 studies | 78% ± 9% | |
| ciliated cell | 7 studies | 25% ± 11% | |
| epithelial cell | 6 studies | 38% ± 30% | |
| club cell | 6 studies | 54% ± 19% | |
| basal cell | 5 studies | 39% ± 16% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 4 studies | 32% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 9355.98 | 652 / 653 | 84% | 66.11 | 508 / 605 |
| lung | 99% | 5833.44 | 575 / 578 | 45% | 22.92 | 524 / 1155 |
| bladder | 0% | 0 | 0 / 21 | 5% | 1.99 | 24 / 504 |
| brain | 3% | 17.65 | 90 / 2642 | 0% | 0 | 0 / 705 |
| uterus | 0% | 0 | 0 / 170 | 1% | 0.10 | 5 / 459 |
| ovary | 1% | 10.33 | 1 / 180 | 0% | 0.05 | 1 / 430 |
| stomach | 0% | 0 | 0 / 359 | 1% | 0.07 | 2 / 286 |
| skin | 0% | 0.28 | 1 / 1809 | 0% | 0.04 | 2 / 472 |
| pancreas | 0% | 2.34 | 1 / 328 | 0% | 0 | 0 / 178 |
| prostate | 0% | 0 | 0 / 245 | 0% | 0.02 | 1 / 502 |
| blood vessel | 0% | 0.69 | 2 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.47 | 1 / 929 | 0% | 0 | 0 / 0 |
| breast | 0% | 0 | 0 / 459 | 0% | 0.01 | 1 / 1118 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| esophagus | 0% | 0 | 0 / 1445 | 0% | 0 | 0 / 183 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| intestine | 0% | 0 | 0 / 966 | 0% | 0 | 0 / 527 |
| kidney | 0% | 0 | 0 / 89 | 0% | 0 | 0 / 901 |
| liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0042060 | Biological process | wound healing |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005576 | Cellular component | extracellular region |
| GO_0042599 | Cellular component | lamellar body |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0045334 | Cellular component | clathrin-coated endocytic vesicle |
| Gene name | SFTA3 |
| Protein name | Surfactant associated 3 Surfactant-associated protein 3 (Surfactant-associated protein H) (SP-H) |
| Synonyms | SFTPH |
| Description | FUNCTION: Putative surfactant protein. May be involved in wound healing and in the reduction of the surface tension at the ocular surface. . |
| Accessions | F8VVG2 ENST00000546983.2 P0C7M3 |